Company news

Helix BioPharma Corp. news in 2025

Helix BioPharma Corp.'s news releases, calls and decks from 2025, newest first.

View company

Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Three-Month Period Ended October 31, 2025

December 15, 2025

Helix BioPharma Corp. Announces Fiscal 2025 Year-End Results

October 29, 2025

Helix BioPharma Responds to Market Activity

October 6, 2025

Helix BioPharma Announces Presentation at Q3 Investor Summit Virtual on 16 September 2025

September 9, 2025

Helix BioPharma Concludes Review, Will Not Proceed with Proposed Equity Draw-Down Subscription Facility with GEM

September 5, 2025

Helix BioPharma Concludes Review, Will Not Proceed With Proposed Equity Draw-Down Subscription Facility With GEM

September 5, 2025

Helix Biopharma Corp. Announces Closing of Private Placement, in Preparation for Institutional Investment and NASDAQ Uplisting

August 22, 2025

Helix Biopharma Corp. Announces Publication in Frontiers in Oncology on the Effects of L-DOS47 as Monotherapy in NSCLC

August 13, 2025

Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Nine Month Period Ended April 30, 2025

June 16, 2025

Helix BioPharma Corp. Announces CFO Appointment to Support Strategic Growth and Upcoming Milestones

June 2, 2025

Helix BioPharma (TSX: "HBP", OTC PINK: "HBPCD", FRANKFURT: "HBP0") Secures Pre-IND Candidates LEUMUNA(TM) and GEMCEDA(TM) in Strategic Acquisition from the Laevoroc Group

May 20, 2025

Helix BioPharma Corp. (HBP.TO) Signs Capital Raising Agreement with Kerentech Consulting Ltd.

May 14, 2025

Helix BioPharma Corp. Appoints New COO and Communications Director to Accelerate Growth and Deliver on its Mission Against Hard-to-Treat Cancers

April 24, 2025

Helix BioPharma Corp. Appoints Dr. Thomas Mehrling as Chief Executive Officer to Drive Ambitious Clinical Development Plan

April 10, 2025

Helix BioPharma Corp. Announces Engagement of Independent Trading Group to Provide Market-Making Services

April 3, 2025

Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Three and Six Month Periods Ended January 31, 2025

March 18, 2025

Helix BioPharma Corp. Announces Upcoming Poster Presentation at the 20th European Molecular Imaging Meeting in Bilbao, Spain

March 11, 2025

Helix Biopharma Corp. Expands Leadership Team With World-Class Oncology and Scientific Experts

March 6, 2025

Helix Biopharma Corp. Expands Leadership Team with World-Class Oncology and Scientific Experts

March 6, 2025

Helix BioPharma Corp. receives approval for the Extension of Annual General and Special Meeting to Seek Approval of Asset Acquisitions and Proposed Financing

March 3, 2025

Helix BioPharma Corp. Extends Date of Annual General and Special Meeting to Seek Approval of Asset Acquisitions and Proposed Financing

February 24, 2025

Helix Biopharma Corp. Announces Closing of Private Placement of Common Shares

January 9, 2025

Decks in 2025